Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma

Published:2023-04 Issue:4 Volume:21 Page:960-969.e1
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Huang Yu-Han,Chan Chi,Lee Hye-Won,Huang Claire,Chen Yen-Ju,Liu Po-Chun,Lu Sheng-Nan,Chuang Wan-Long,Huang Jee-Fu,Yu Ming-Lung,Koshiol Jill,Lee Mei-Hsuan

Funder

National Institutes of Health

National Cancer Institute

Division of Cancer Epidemiology and Genetics, National Cancer Institute

Ministry of Science and Technology, Taiwan

National Health Research Institutes

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe;Younossi;Hepatology,2016

2. Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009;Younossi;Hepatology,2015

3. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States;Wong;Gastroenterology,2015

4. Updated definitions of healthy ranges for serum alanine aminotransferase levels;Prati;Ann Intern Med,2002

5. Nonalcoholic steatohepatitis: a review;Sheka;JAMA,2020

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility;Journal of Gastroenterology and Hepatology;2024-08-27

2. Real-World Risk and Outcome of Liver Cirrhosis in Patients with Hyperlipidemia Treated with Red Yeast Rice: A Retrospective Cohort Study;Journal of Multidisciplinary Healthcare;2024-07

3. SGLT2 Inhibitor and GLP-1 Receptor Agonist Co-Treatment: Liver Function Effects in Patients with Type 2 Diabetes Mellitus;2024-06-06

4. Chronic Viral Hepatitis B and C Outweigh MASLD in the Associated Risk of Cirrhosis and HCC;Clinical Gastroenterology and Hepatology;2024-06

5. Assessment of Cognitive Function in Romanian Patients with Chronic Alcohol Consumption;Gastroenterology Insights;2024-05-17